|
Real Time
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
| 5,980 EUR | -0,33% |
|
+1,01% | -8,56% |
| 23/11 | Farmazwaargewichten helpen Bel20 schade beperken | AM |
| 19/11 | Hyloris Pharmaceuticals benoemt co-CEO tot enige Chief Executive Officer | MT |
Belangrijkste concurrenten
Toevoegen aan een lijst 0 geselecteerde | Dividendrendement (Y) | Dividendrendement (Y+1) | k/w-verhouding (Y) | Koers-boekwaarde (Y) | EV/omzet (Y) | Beurskap. / EBITDA (Y) | Beurskap. / EBIT (Y) | Kap.($) | |
|---|---|---|---|---|---|---|---|---|---|
 | - | - | -14.29x | - | 17.27x | -12.01x | -11.38x | 195 mln. | |
| 0,59% | 0,66% | 44.17x | 33.26x | 14.63x | 32.47x | 34.87x | 905 mld. | |
| 2,56% | 2,64% | 19.27x | 6.19x | 5.41x | 14.97x | 16.42x | 487 mld. | |
| 2,89% | 3% | 52.81x | -545.82x | 7.48x | 17.71x | 18.22x | 400 mld. | |
| 3,18% | 3,24% | 18.03x | 6.44x | 4.54x | 11.37x | 12.9x | 330 mld. | |
| 1,78% | 1,88% | 27.29x | 6.16x | 5.16x | 15.31x | 16.13x | 281 mld. | |
| 3,07% | 3,2% | 18.36x | 5.75x | 4.97x | 11.67x | 12.58x | 255 mld. | |
| 3,24% | 3,39% | 12.89x | 4.6x | 4.21x | 9x | 10.17x | 248 mld. | |
| 3,76% | 3,73% | 13.42x | 7.33x | 4.8x | 9.94x | 11.49x | 214 mld. | |
| 2,9% | 3,06% | 25.21x | 19.93x | 6.12x | 10.51x | 14.04x | 178 mld. | |
| 2,73% | 2,85% | 17.68x | 6.63x | 5.58x | 10.21x | 12.28x | 150 mld. | |
| 6,55% | 6,69% | 13.48x | 1.64x | 3.02x | 7.58x | 8.74x | 148 mld. | |
| 4,89% | 5,05% | 12.36x | 1.32x | 2.66x | 8.65x | 9.63x | 120 mld. | |
| -.--% | -.--% | 29.33x | 6.19x | 8.88x | 19.18x | 19.93x | 116 mld. | |
| 4,74% | 4,88% | 12.32x | 5.36x | 2.91x | 8.45x | 8.81x | 106 mld. | |
| 3,6% | 3,87% | 12.89x | 5.05x | 2.67x | 7.87x | 9.02x | 96,56 mld. | |
| 3,08% | 1,57% | 31.62x | 6.88x | 10.19x | 19.94x | 21.32x | 87,18 mld. | |
| -.--% | -.--% | 200.41x | 72.37x | 15.74x | 103.92x | 100.59x | 60,52 mld. | |
| 0,45% | 0,52% | 46.45x | 6.91x | 11.22x | 36.85x | 38.76x | 57,93 mld. | |
| Gemiddelde | 2,78% | 2,79% | 31,25x | -19,10x | 7,23x | 18,08x | 19,18x | 223,12 mld. | |
| Gewogen gemiddelde per kap. | 2,48% | 2,54% | 30,41x | -38,89x | 7,53x | 18,57x | 20,02x |
- Beurs
- Aandelen
- Koers HYL
- Sector Hyloris Pharmaceuticals SA
- Sectorale dividenden
Kies jouw editie
Alle financiële informatie op nationaal niveau
